Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $136.8 million.

  • Bio-Techne's Operating Expenses fell 658.92% to $136.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $675.8 million, marking a year-over-year increase of 1559.42%. This contributed to the annual value of $688.0 million for FY2025, which is 2219.7% up from last year.
  • Latest data reveals that Bio-Techne reported Operating Expenses of $136.8 million as of Q4 2025, which was down 658.92% from $140.5 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Operating Expenses peaked at $222.7 million during Q2 2025, and registered a low of $99.6 million during Q1 2021.
  • For the 5-year period, Bio-Techne's Operating Expenses averaged around $133.3 million, with its median value being $126.3 million (2022).
  • In the last 5 years, Bio-Techne's Operating Expenses surged by 4507.59% in 2021 and then plummeted by 801.82% in 2023.
  • Quarter analysis of 5 years shows Bio-Techne's Operating Expenses stood at $121.3 million in 2021, then fell by 4.84% to $115.5 million in 2022, then increased by 20.02% to $138.6 million in 2023, then grew by 5.69% to $146.5 million in 2024, then fell by 6.59% to $136.8 million in 2025.
  • Its Operating Expenses was $136.8 million in Q4 2025, compared to $140.5 million in Q3 2025 and $222.7 million in Q2 2025.